StayWell Guam Inc.
Drug Recall: Artificial Tears Lubricant Eye Drops
StayWell Insurance | February 3, 2023 | Maite, GU
Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops, distributed by Aru Pharma/EzriCare, LLC and Delsam Pharma, to the consumer level, due to possible contamination. The Centers for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo-β-lactamase (VIM)- and Guiana-Extended Spectrum-β-Lactamase (GES)- producing, carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare. To date, there are 55 reports of adverse events including eye infections, permanent loss of vision, and a death with a bloodstream infection.
Risk Statement: Use of contaminated artificial tears can result in the risk of eye infections that could result in blindness.
Artificial Tears (carboxymethylcellulose sodium) Lubricant Eye Drops, 10 mg in 1 mL, ½ fl oz (15 ml) bottle are used as a protectant against further irritation or to relieve dryness of the eye for the temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun.
The following are the affected NDCs (product identification):
|NDC #||UPC #|
|EzriCare Artificial Tears Lubricant Eye Drops||79503-0101-15 3 79503 10115 7|
|Delsam Pharma Artificial Tears Lubricant Eye Drops||72570-0121-15 72570-0121-15|
Global Pharma Healthcare is notifying the distributors of this product, Aru Pharma, Inc. and Delsam Pharma and is requesting that wholesalers, retailers and customers who have the recalled product should stop use.
Consumers with questions regarding this recall can contact the distributors: Aru Pharma/Ezricare, LLC by phone: 1-518-738-7602 or by e-mail: [email protected] from Monday to Friday, 11am to 4pm EST; or DELSAM Pharma LLC by phone: 1-866-826-1309 or by e-mail: [email protected] from Monday to Friday from 11am to 4pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these over-the-counter drug products.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
For additional information regarding the recall, please refer to the FDA recall notification at: